Who invested in ImmunityBio, Inc.?
ImmunityBio, Inc.'s investors include Oberland Capital. Oberland Capital led its latest round.
United States · Funded startup
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$320Mraised across 1 round since 2024, from 1 source
Reported by Firms' own news pagesSEC filing: $470M sold, first sale Sept 2023
ImmunityBio, Inc.'s investors include Oberland Capital. Oberland Capital led its latest round.
ImmunityBio, Inc. has raised $320M across 1 round since 2024.
ImmunityBio, Inc.'s most recent round was an Undisclosed round of $320M in Jan 2024, led by Oberland Capital.
Its most recent round, $320M in Jan 2024, is also its largest on record.
ImmunityBio, Inc.'s first round on record, in Jan 2024, was backed by Oberland Capital.
ImmunityBio, Inc.'s latest named round is an Undisclosed round, in Jan 2024.
ImmunityBio, Inc. is based in the United States.
Oberland Capital led the Undisclosed round in 2024.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.